When was Future Meds founded?

Future Meds was founded in 2011 and raised its 1st funding round 10 years after it was founded.

Where is Future Meds located?

Future Meds is headquartered in Wrocław, Poland.

How many employees does Future Meds have?

As of Sep 30, 2026, the latest employee count at Future Meds is 399.

Is Future Meds a funded company?

Future Meds is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on 2021.

When was the latest funding round of Future Meds?

Future Meds' latest funding was a $***** PE round on 2021, with participation from 0 investor.

Where does Future Meds rank among its competitors?

Future Meds ranks 18th amongst 209 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioMADE, which secured $2.42M in Aug, 2025.

Future Meds - 2026 Company Profile, Funding & Competitors

Q: Who are the top competitors of Future Meds?

Future Meds' top competitors include Javara Research, Alcanza Clinical Research and The START Center for Cancer Research. Among them, BioMADE secured the most recent funding round in August, 2025.

Company Details

Network of research sites providing clinical trial services to sponsors. They offer patient recruitment, clinical trial management, and data delivery. The network supports trials across multiple therapy areas. It facilitates research with experienced investigators and healthcare professionals.

Key Metrics

Founded Year

2011

Location

Wrocław, Poland

Stage

Late Stage

Latest Funding Round

PE, 2021, $*****

Investors

Phoenix Equity Partners & 1 more

Ranked

18^th among 209 active competitors

Employee Count

399 as on Sep 30, 2026

Similar Companies

Javara Research & 253 more

View Future Meds' full profile

Future Meds has raised funding over 1 round. Future Meds has 2 institutional investors.

Here is the list of recent funding rounds of Future Meds:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2021	9208	PE	7848	1616	2710	9665

Access funding benchmarks and valuations. Sign up today!

View details of Future Meds's funding rounds and investors

Future Meds' employee count trend

Future Meds has 399 employees as of Sep 26. Here is Future Meds's employee count trend over the years:

Uncover Future Meds' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Future Meds include Javara Research, Alcanza Clinical Research and The START Center for Cancer Research. Here is the list of Top 10 competitors of Future Meds, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Javara Research 2018, Winston-salem (United States), Series B	Integrating clinical research at the point of care for better outcomes	$45M	General Atlantic, Dioko Ventures & 1 others	44/100
2nd	Alcanza Clinical Research 2021, Methuen (United States), Funding Raised	Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation	-	Impact Engine, Martis Capital	43/100
3rd	The START Center for Cancer Research 2007, San Antonio (United States), Series B	Provider of early-phase oncology clinical trials and research services	$16.9M	Warburg Pincus	42/100
4th	Vial 2020, San Francisco (United States), Series B	-	$100M	General Catalyst, BoxGroup & 1 others	42/100
5th	BioMADE 2020, Saint Paul (United States), Funding Raised	Provider of clinical trial research site services for biopharma sector	-	National Oceanic and Atmospheric Administration, National Science Foundation ... Read more	42/100
6th	Tekton Research 2006, Austin (United States), Acquired	Clinical research site network conducting Phase 1-4 trials across multiple therapeutic areas	-	-	41/100
7th	Care Access 1998, Boston (United States), Unfunded	CRO offering clinical sites which conduct clinical trials	-	-	39/100
8th	Summit Clinical Research 2018, San Antonio (United States), Acquired	CRO providing research site for clinical development services	-	LongueVue Capital	38/100
9th	Meridien Research 2000, Tampa (United States), Acquired	Clinical trial services for research and development	-	Balance Point Capital, Fletch Equity	36/100
10th	Sampled 1999, Motherwell (United Kingdom), Funding Raised	Provider of smart laboratory services for drug developers	-	Pioneer Group	35/100
18th	Future Meds 2011, Wrocław (Poland), Late Stage	Network of research sites providing clinical trial services to sponsors	-	Phoenix Equity Partners & 1 others	30/100